Hjem › Metastatisk kreft › Iowa
Kliniske studier for Metastatisk kreft i Iowa
10 studier for Metastatisk kreft søker deltakere på steder i Iowa.
Byer i Iowa
Offisiell studietekst (engelsk)
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
- UI Health Care Mission Cancer and Blood - Ankeny Clinic, Ankeny
- Mercy Hospital, Cedar Rapids
- Oncology Associates at Mercy Medical Center, Cedar Rapids
- og 4 flere
RekruttererFase 2
Alle aldre · Alle kjønn · Oppdatert 5. okt. 2026 · NCT05564377A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
- Research Site, Des Moines
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 25. sep. 2026 · NCT06103864A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
- University of Iowa, Iowa City
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 22. sep. 2026 · NCT07174336A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors
- University of Iowa, Iowa City
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 28. aug. 2026 · NCT07029399A Study of ASP1002 in Adults for Treatment of Solid Tumors
- University of Iowa Hospitals, Iowa City
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 23. jul. 2026 · NCT05719558Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors
- University of Iowa Health Care, Iowa City
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 11. jun. 2026 · NCT052833305-Azacitidine Plus PD-1/PD-L1 Inhibitor With PD-1/PD-L1 Refractory Tumors
- University of Iowa Health Care, Iowa City
RekruttererFase 1
Alder 18 til 99 · Alle kjønn · Oppdatert 28. mai 2026 · NCT07404332A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
- University of Iowa, Iowa City
RekruttererFase 2/3
Alle aldre · Alle kjønn · Oppdatert 2. apr. 2026 · NCT06581406Ivosidenib in Participants With Locally Advanced or Metastatic Conventional Chondrosarcoma Untreated or Previously Treated With 1 Systemic Treatment Regimen
- University of Iowa Hospitals & Clinics- Holden Comprehensive Cancer Center, Iowa City
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 6. feb. 2026 · NCT06127407SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Iowa City
RekruttererObservasjonsstudie
Alle aldre · Alle kjønn · Oppdatert 28. okt. 2025 · NCT03452774Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.